Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Global Forecast 2024-2030

Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Global Forecast 2024-2030


The Glucosamine Market size was estimated at USD 800.48 million in 2023 and expected to reach USD 841.71 million in 2024, at a CAGR 5.28% to reach USD 1,147.62 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glucosamine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glucosamine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co. Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd..

Market Segmentation & Coverage



This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Types
Glucosamine Hydrochloride
Glucosamine Sulfate Potassium Chloride
Glucosamine Sulfate Sodium Chloride
N-Acetylglucosamine
Form
Capsules
Liquid
Powder
Tablets
Source
Animal
Crab

Lobster

Shrimp
Plant
Corn

Mushrooom
Application
Cosmetics
Dietary Supplements
Health Food
Medicine
Veterinary
Distribution Channel
Online Stores
Pharmacies
Retail Stores
Supermarkets
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Glucosamine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glucosamine Market?
3. What are the technology trends and regulatory frameworks in the Glucosamine Market?
4. What is the market share of the leading vendors in the Glucosamine Market?
5. Which modes and strategic moves are suitable for entering the Glucosamine Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Glucosamine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing obese population coupled with increasing number of arthritis cases
5.1.1.2. Increasing use of glucosamine in bone and joint health supplements
5.1.1.3. Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
5.1.2. Restraints
5.1.2.1. High cost related to glucosamine products
5.1.3. Opportunities
5.1.3.1. Launch and approval of novel glucosamine products
5.1.3.2. Focus of manufacturers on R&D activities in the field of glucosamine
5.1.4. Challenges
5.1.4.1. Several side effects associated with glucosamine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Glucosamine Market, by Types
6.1. Introduction
6.2. Glucosamine Hydrochloride
6.3. Glucosamine Sulfate Potassium Chloride
6.4. Glucosamine Sulfate Sodium Chloride
6.5. N-Acetylglucosamine
7. Glucosamine Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Liquid
7.4. Powder
7.5. Tablets
8. Glucosamine Market, by Source
8.1. Introduction
8.2. Animal
8.3.1. Crab
8.3.2. Lobster
8.3.3. Shrimp
8.3. Plant
8.4.1. Corn
8.4.2. Mushrooom
9. Glucosamine Market, by Application
9.1. Introduction
9.2. Cosmetics
9.3. Dietary Supplements
9.4. Health Food
9.5. Medicine
9.6. Veterinary
10. Glucosamine Market, by Distribution Channel
10.1. Introduction
10.2. Online Stores
10.3. Pharmacies
10.4. Retail Stores
10.5. Supermarkets
11. Americas Glucosamine Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Glucosamine Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Glucosamine Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Aden Healthcare
15.1.2. Andra Medi Pharma India Pvt. Ltd.
15.1.3. Bio-gen Extracts Pvt. Ltd.
15.1.4. Captek Softgel International Inc.
15.1.5. Cargill, Inc.
15.1.6. Cellmark AB
15.1.7. Enomark Pharma
15.1.8. Ethical Naturals Inc.
15.1.9. Fabrichem, Inc.
15.1.10. Fermentis Life Sciences
15.1.11. GlucosaGreen
15.1.12. Golden Shell Pharmaceutical Co. Ltd.
15.1.13. Kabir Lifesciences
15.1.14. Koyo Chemical Co., Ltd.
15.1.15. Lifecare Neuro Products Limited
15.1.16. Manus Aktteva Biopharma LLP
15.1.17. Panvo Organics Pvt Ltd.
15.1.18. Pax Healthcare
15.1.19. Schiff Nutrition International Inc.
15.1.20. SMPNutra
15.1.21. Spectrum Chemical Manufacturing Corp.
15.1.22. TSI Health Sciences, Inc.
15.1.23. United Laboratories, Inc.
15.1.24. Velnex Medicare
15.1.25. Wellable Marine Biotech Holding Limited
15.1.26. Zhejiang AOXING Biotechnology Co., Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. GLUCOSAMINE MARKET RESEARCH PROCESS
FIGURE 2. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLUCOSAMINE MARKET DYNAMICS
FIGURE 7. GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
FIGURE 8. GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 12. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings